| 101167-5 | Metonitazene/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101168-3 | Metonitazene (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 101169-1 | 2-methyl AP-237 (Urine, confirmatory method) | DRUG/TOX |
| 10117-0 | ST wave end displacement in lead V6 | EKG.MEAS |
| 101170-9 | Soluble urokinase plasminogen activator receptor | CHEM |
| 101171-7 | 2-methyl AP-237/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101172-5 | Chlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis rRNA panel - Specimen (naa with probe detection) | PANEL.MICRO |
| 101173-3 | Melatonin (oral fluid) (Saliva) | CHEM |
| 101174-1 | 17-Hydroxyprogesterone (oral fluid) (Saliva) | CHEM |
| 101175-8 | 3-Methoxytyramine.free/Creatinine | CHEM |
| 101176-6 | Normetanephrine Free/Creatinine | CHEM |
| 101177-4 | Metanephrine Free/Creatinine | CHEM |
| 101178-2 | Pneumocystis jirovecii DNA in Respiratory system specimen (naa with probe detection) | MICRO |
| 101179-0 | Immunoglobulin light chains.free/Protein.total in 24 hour Urine | CHEM |
| 10118-8 | ST wave mid displacement in lead AVF | EKG.MEAS |
| 101180-8 | 2-methyl AP-237 (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 101181-6 | MDMB-4en-PINACA (Urine, confirmatory method) | DRUG/TOX |
| 101182-4 | MDMB-4en-PINACA/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101183-2 | MDMB-4en-PINACA (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 101184-0 | 4F-MDMB-BINACA (Urine, confirmatory method) | DRUG/TOX |
| 101185-7 | 4F-MDMB-BINACA/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101186-5 | 4F-MDMB-BINACA (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 101187-3 | ADB-BUTINACA (Urine, confirmatory method) | DRUG/TOX |
| 101188-1 | ADB-BUTINACA/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101189-9 | ADB-BUTINACA (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 10119-6 | ST wave mid displacement in lead AVL | EKG.MEAS |
| 101190-7 | 5F-MDMB-PICA (Urine, confirmatory method) | DRUG/TOX |
| 101191-5 | 5F-MDMB-PICA/Creatinine (Urine, confirmatory method) | DRUG/TOX |
| 101192-3 | 5F-MDMB-PICA (Urine, qualitative, confirmatory method) | DRUG/TOX |
| 101193-1 | Sphincter excision plane in Colorectal cancer specimen | PATH |
| 101194-9 | Mesocolic excision plane in Colorectal cancer specimen | PATH |
| 101195-6 | Depth of invasion beyond muscularis propria in Colorectal cancer specimen | PATH |
| 101196-4 | Inflammatory cell infiltrate in Colorectal cancer specimen | PATH |
| 101197-2 | Lymph nodes with metastasis/Lymph nodes examined in Colorectal cancer specimen | PATH |
| 101198-0 | Albumin (nephelometry) | CHEM |
| 101199-8 | Protein.monoclonal band 5/Protein.total (electrophoresis) | CHEM |
| 1012-4 | E sup(w) Ab (qualitative) | BLDBK |
| 10120-4 | ST wave mid displacement in lead AVR | EKG.MEAS |
| 101200-4 | Protein.monoclonal band 6/Protein.total (electrophoresis) | CHEM |
| 101201-2 | Measles virus IgG Ab index and CSF | MICRO |
| 101202-0 | Mumps virus IgG Ab index and CSF | MICRO |
| 101203-8 | Herpes simplex virus 1+2 IgG Ab index and CSF | MICRO |
| 101204-6 | Varicella zoster virus IgA Ab (immunoassay) | MICRO |
| 101205-3 | Plasmodium sp IgG Ab (immunoassay) | MICRO |
| 101206-1 | Dengue virus NS1 Ag (immunoassay) | MICRO |
| 101207-9 | Hepatitis E virus IgG Ab (qualitative, line blot) | MICRO |
| 101208-7 | Hepatitis E virus IgM Ab (qualitative, line blot) | MICRO |
| 101209-5 | Hantavirus IgG panel - Serum or Plasma (line blot) | PANEL.MICRO |
| 10121-2 | ST wave mid displacement in lead I | EKG.MEAS |
| 101210-3 | Hantavirus puumala IgG Ab (qualitative, line blot) | MICRO |